IP Library › Assignment 056062/0339
Patent Assignment
Reel/Frame 056062/0339

Change of Name

Recorded: 2021-04-27 Pages: 9
Assignor
INTREXON CORPORATION
Executed: 2021-01-29
Assignee
PRECIGEN, INC.
20358 SENECA MEADOWS PARKWAY, BLACKSBURG, VIRGINIA, 24060
Covered Properties (8)
CD33 Specific Chimeric Antigen Receptors
Application: 15/616,869 →
Publication: US US20180002397A1
Polypeptide Compositions Comprising Spacers
Application: 16/163,233 →
Publication: US US20190111080A1
Steroid Administration and Immunotherapy
Application: 16/421,763 →
Publication: US US20190351019A1
Modulating Expression of Polypeptides via New Gene Switch Expression Systems
Application: 15/867,500 →
Publication: US US20180291384A1
Modulating Expression of Polypeptides via New Gene Switch Expression Systems
Application: 16/881,871 →
Publication: US US20200283778A1
Expression of Novel Cell Tags
Application: 16/001,759 →
Publication: US US20180362940A1
MUC16 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 16/431,193 →
Publication: US US20190375854A1
Ror-1 Specific Chimeric Antigen Receptors and Uses Thereof
Application: 17/143,386 →
Publication: US US20210177902A1
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 26, 2017
From: EMTAGE, PETER; SHAH, RUTUL R.; CHAN, TIM; YARLAGADDA, RAMYA
To: INTREXON CORPORATION
Reel/Frame 043104/0200 →
Assignment of Assignor's Interest Jul 11, 2018
From: SHAH, RUTUL R.; BOLINGER, CHERYL G.; REED, THOMAS D.
To: INTREXON CORPORATION
Reel/Frame 046320/0093 →
Assignment of Assignor's Interest Aug 13, 2018
From: SHAH, RUTUL R.; EMTAGE, PETER; YARLAGADDA, RAMYA
To: INTREXON CORPORATION
Reel/Frame 046624/0791 →
Assignment of Assignor's Interest Dec 17, 2018
From: SHAH, RUTUL R
To: INTREXON CORPORATION
Reel/Frame 047791/0181 →
Assignment of Assignor's Interest Jul 2, 2019
From: SABZEVARI, HELEN; SHAH, RUTUL
To: INTREXON CORPORATION
Reel/Frame 049649/0058 →
Assignment of Assignor's Interest Aug 13, 2019
From: COOPER, LAURENCE J
To: ZIOPHARM ONCOLOGY, INC.
Reel/Frame 050039/0397 →
Assignment of Assignor's Interest Aug 13, 2019
From: ZIOPHARM ONCOLOGY, INC.
To: INTREXON CORPORATION
Reel/Frame 050038/0012 →
Change of Name May 10, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 056183/0285 →
Change of Name May 10, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 056184/0262 →
Change of Name May 10, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 056184/0295 →
Change of Name May 10, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 056184/0892 →
Change of Name May 10, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 056185/0138 →
Change of Name May 10, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 056185/0176 →
Assignment of Assignor's Interest May 10, 2021
From: SHAH, RUTUL R.; BOLINGER, CHERYL G.; REED, THOMAS D.
To: INTREXON CORPORATION
Reel/Frame 056185/0353 →
Assignment of Assignor's Interest Aug 25, 2021
From: SHAH, RUTUL R.; CHEN, CHANGHUNG; BOLINGER, CHERYL G.; KURELLA, VINODHBABU
To: INTREXON CORPORATION
Reel/Frame 057280/0261 →
Change of Name Aug 27, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 057361/0671 →
Patent Security Agreement Sep 3, 2025
From: PRECIGEN, INC.; GENVEC LLC; PRECIGEN ACTOBIO, INC.; EXEMPLAR GENETICS, LLC
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072828/0564 →